This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_SKIN_NOS_EXALLC for full statistics.
Carcinoma in situ of skin, other sites/unspecified
CD2_INSITU_SKIN_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
393 |
4. Check minimum number of eventsNone |
393 |
5. Include endpointsNone |
393 |
6. Filter based on genotype QC (FinnGen only) |
393 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin, other sites/unspecified
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin, other sites/unspecified
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 393 | 179 | 214 |
| Unadjusted period prevalence (%) | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | 76.42 | 74.70 | 77.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 324
- Matched controls
- 3237
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
4874.6
231.3
195
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
165.2
144
*
L57.0
ICD-10 Finland
Actinic keratosis
31.4
152.5
240
270
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
21.0
110.1
183
188
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
32.8
86.7
116
54
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
30.2
78.3
107
52
ZXC50
NOMESCO Finland
Cryotherapy
24.2
76.8
113
70
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
12.8
75.7
154
214
ZXC15
NOMESCO Finland
Use of photodynamic technique
44.2
71.5
88
27
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
74.1
70.7
79
14
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
109.2
58.2
62
7
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
13.2
58.2
110
121
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
11.3
55.7
115
150
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
22.0
54.9
82
49
TQW99
NOMESCO Finland
Other minor procedure on skin
13.8
53.1
97
97
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
18.9
51.9
82
57
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
51.1
49.6
59
14
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
21.3
44.8
67
39
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.0
42.0
85
101
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.3
41.0
131
316
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
53.3
39.0
46
10
S18
ICPC
Laceration/cut
4.5
35.0
221
1050
D06BB10
ATC
imiquimod; topical
10.3
33.1
68
81
SPAT1153
SPAT
Removal of sutures
4.1
31.2
181
765
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
20.4
30.7
46
26
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
14.6
29.3
50
40
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
22.8
29.1
42
21
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
6.9
28.8
78
143
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
11.6
26.4
50
50
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
54.9
25.7
30
6
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
16.0
25.2
41
29
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
34.1
24.2
31
10
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
36.5
23.8
30
9
ZZR00
NOMESCO Finland
Flap of skin
11.6
22.9
43
42
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.4
22.6
43
43
127
Kela drug reimbursment
Transplant complication
26.2
22.6
31
13
ZZA00
NOMESCO Finland
Split skin graft
9.5
22.3
47
57
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
46.9
21.7
26
6
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
26.6
19.9
27
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.2
19.3
48
76
TQW80
NOMESCO Finland
Local dermatologic skincare
13.5
18.6
32
26
Z94.0
ICD-10 Finland
Kidney transplant status
26.9
18.5
25
10
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
35.2
18.2
23
7
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
44.8
17.5
21
5
L82
ICD-10 Finland
Seborrhoeic keratosis
3.4
17.2
99
371
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
37.3
16.9
21
6
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
22.4
16.2
23
11
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
35.4
15.9
20
6
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
167.8
15.6
16
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
21.3
15.3
22
11
L04AA01
ATC
[U] ciclosporin; systemic
15.1
14.8
24
17
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
14.7
14
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
13.4
14.6
25
20
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
16.4
14.6
23
15
ZXC20
NOMESCO Finland
Use of chemical agents
8.7
14.4
31
39
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.7
14.3
42
83
A98
ICPC
Health maint/preventive medicine
4.5
14.1
304
2502
L04AD01
ATC
ciclosporin; systemic
14.5
13.9
23
17
L04AA06
ATC
mycophenolic acid; systemic
15.6
13.8
22
15
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
35.7
13.6
17
5
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
+∞
13.6
13
*
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
145.9
13.6
14
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.6
13.3
39
77
D07AC01
ATC
betamethasone; topical
2.5
13.1
139
747
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.1
13.0
29
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
12.8
84
338
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
33.5
12.7
16
5
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
25.5
12.6
17
7
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
10.7
12.2
23
23
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.9
12.0
25
30
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
48.6
12.0
14
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.1
11.6
72
277
S77
ICPC
Malignant neoplasm of skin
12.5
11.5
20
17
DAB10
NOMESCO Finland
Partial excision of auricle
36.4
11.4
14
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
26.1
11.2
15
6
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
5.9
11.2
31
57
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
14.6
11.1
18
13
XQ848
NOMESCO Finland
Dermatological photography
7.6
11.0
25
35
E0000UV
ATC
NA
2.3
11.0
147
866
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
10.1
10.9
21
22
J01DB01
ATC
cefalexin; oral
2.6
10.9
267
2088
A12AA04
ATC
calcium carbonate; oral
9.0
10.7
22
26
DAB00
NOMESCO Finland
Excision of lesion of auricle
9.0
10.7
22
26
B07.9
ICD-10 Finland
Verruca simplex
7.2
10.6
25
37
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
5.8
10.4
29
54
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
19.6
10.4
15
8
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
24.3
10.3
14
6
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.3
10.3
22
28
S29
ICPC
Skin symptom/complaint other
2.6
9.8
80
364
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
9.8
182
1219
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.6
289
2411
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
9.1
9.4
19
22
ZQZ00
NOMESCO Finland
Treatment of several skin areas
11.1
9.4
17
16
D07AB08
ATC
desonide; topical
3.1
9.2
53
194
L04AX01
ATC
azathioprine; systemic
5.4
9.2
27
54
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
16.2
9.1
14
9
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
7.2
9.0
21
31
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
8.8
71
318
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
51.4
8.7
10
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
51.4
8.7
10
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
12.0
8.7
15
13
XQ845
NOMESCO Finland
Dermatoscopy
8.2
8.5
18
23
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
8.4
8
*
A46
ICD-10 Finland
Erysipelas
2.5
8.2
71
330
A11CC03
ATC
alfacalcidol; systemic
5.8
8.1
22
40
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.2
8.1
24
49
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.1
137
862
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
22.7
8.1
11
5
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.2
7.9
14
13
WX110
NOMESCO Finland
Local anesthesy
2.0
7.8
202
1487
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
46.1
7.7
9
*
-54
ICPC
Repair/fix-suture/cast/prosth device
5.4
7.7
22
43
SPAT1312
SPAT
General health counselling
2.1
7.6
111
654
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
25.7
7.6
10
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
25.7
7.6
10
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
9.7
7.4
14
15
WXQ99
NOMESCO Finland
Other light therapy
+∞
7.3
7
*
D06BX02
ATC
ingenol mebutate; topical
6.8
7.2
17
26
C02CA01
ATC
prazosin; oral
5.5
7.2
20
38
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
20.6
7.2
10
5
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.9
6.9
152
1036
137
Kela drug reimbursment
Uraemia requiring dialysis
11.3
6.9
12
11
ZZA50
NOMESCO Finland
Full thickness skin graft
9.6
6.8
13
14
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
40.9
6.8
8
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
40.9
6.8
8
*
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
23.1
6.7
9
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
23.1
6.7
9
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
23.1
6.7
9
*
Z3231
NOMESCO Finland
Registered nurse
2.0
6.7
107
648
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
6.6
137
912
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.9
6.5
17
30
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
6.8
6.4
15
23
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
8.4
6.4
13
16
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.5
6.3
12
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
6.3
44
182
ZXE00
NOMESCO Finland
One hour or less
1.8
6.3
136
913
205
Kela drug reimbursment
Chronic hypertension
1.8
6.3
141
958
L01BB01
ATC
NA
27.2
6.3
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
6.2
56
262
TQW40
NOMESCO Finland
Remowal of suture of skin
3.2
6.1
30
99
ZY010
NOMESCO Finland
Hospital outpatient
5.4
6.1
17
33
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
10.3
6.1
11
11
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
6.1
133
895
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.9
6.0
23
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
296
1205
6.90
69.18
5.4
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
162
408
6.05
65.21
2.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
55
6.46
19.36
4.2
3.4
%
60.1
60.9
0.09
33
55
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
52
6.61
19.23
3.2
2.8
e9/l
5.2
4.7
0.33
32
52
(3013826) Glucose [Moles/volume] in Serum or Plasma
290
1979
2.78
17.93
5.7
5.0
mmol/l
6.8
6.9
0.71
279
1860
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
97
404
2.86
16.43
5.3
4.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
52
148
3.90
16.32
1.4
1.3
—
—
—
0
0
(4035726)
76
284
3.08
15.58
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
122
593
2.53
15.07
6.3
4.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
211
1335
2.25
13.94
17.9
10.4
e9/l
0.0
0.0
0.31
183
1098
(3002179) Metamyelocytes/100 leukocytes in Blood
64
240
2.99
12.93
4.6
3.8
%
0.3
0.6
1.15
23
72
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
258
1805
2.25
12.90
10.0
6.5
mmol/l
1.2
1.2
0.25
193
1501
(3013115) Eosinophils [#/volume] in Blood
232
1565
2.18
12.59
8.5
5.2
e9/l
0.2
0.2
1.02
202
1352
(3021440) Promyelocytes/100 leukocytes in Blood
66
258
2.87
12.36
4.7
4.0
%
0.0
0.1
0.62
25
89
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
344
2757
2.99
12.34
26.9
17.7
ml/min/173m2
63.9
69.9
5.77
308
2290
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
318
2.68
12.02
8.5
3.9
mmol/l
1.2
1.2
0.31
63
278
(3006315) Basophils [#/volume] in Blood
225
1517
2.13
12.01
8.3
5.0
e9/l
0.0
0.0
0.50
199
1290
(3001604) Monocytes [#/volume] in Blood
224
1508
2.13
12.00
8.3
5.0
e9/l
0.6
0.6
0.15
199
1270
(1616796) Gas panel - Central venous blood
32
81
4.21
11.71
5.3
4.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
202
1320
2.09
11.57
5.4
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
88
414
2.45
11.32
2.5
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
225
1541
2.08
11.23
8.4
5.2
e9/l
2.9
1.8
1.00
202
1334
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
358
2973
3.29
11.22
28.7
18.6
mg/l
24.3
27.3
0.99
321
2464
(3025159) Blasts/100 leukocytes in Blood
62
249
2.77
10.99
4.8
4.0
%
0.1
0.1
0.08
23
78
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
336
2710
2.65
10.96
5.1
4.8
mu/l
2.0
2.1
0.19
296
2364
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
366
3095
3.66
10.79
15.4
11.1
u/l
22.0
23.1
0.86
355
2947
(3013707) Erythrocyte sedimentation rate by Westergren method
299
2299
2.26
10.78
5.7
4.3
mm/h
17.6
15.3
1.12
272
2064
(3017181) Myelocytes/100 leukocytes in Blood
66
279
2.64
10.58
4.9
3.8
%
0.6
0.8
0.42
25
98
(3007461) Platelets [#/volume] in Blood
372
3188
4.12
10.51
39.8
27.0
e9/l
228.8
236.8
1.43
366
3090
(3026361) Erythrocytes [#/volume] in Blood
372
3189
4.12
10.48
39.8
27.0
e12/l
4.2
4.3
5.00
363
3076
(3010813) Leukocytes [#/volume] in Blood
372
3189
4.12
10.48
39.9
27.0
e9/l
7.7
6.9
1.18
364
3076
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
79
4.03
10.42
2.2
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
225
1569
2.02
10.37
6.5
4.5
g/l
34.1
34.3
0.17
212
1437
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
62
4.42
10.26
2.2
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
289
2215
2.15
10.16
4.1
3.9
pmol/l
15.2
15.1
0.12
258
1923
(40761536) Microorganisms panel - Urine sediment
67
294
2.54
9.93
8.4
4.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
175
1136
1.97
9.71
5.0
3.6
e6/l
67.5
141.0
0.54
150
893
(42870588) Differential panel, method unspecified - Blood
165
1050
1.98
9.70
9.5
4.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
339
2798
2.54
9.59
8.1
6.8
mmol/mol
41.5
41.5
0.02
303
2529
(40761511) CBC panel - Blood by Automated count
358
3036
3.01
9.54
27.1
17.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
37
5.35
9.45
2.6
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
190
1282
1.93
9.29
5.5
4.1
e6/l
298.1
157.4
0.55
159
956
(3013512) EKG study
167
1082
1.95
9.20
4.8
4.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
135
815
2.00
9.11
4.5
2.8
e6/l
3.9
4.9
0.65
125
714
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
309
2475
2.16
9.04
10.8
7.3
u/l
81.3
80.4
0.07
298
2292
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
197
1354
1.91
9.03
3.5
3.4
ng/l
2500.7
1915.1
0.86
180
1177
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
78
3.79
9.00
2.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
51
4.51
8.98
2.5
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
204
1424
1.90
8.87
9.5
5.2
%
2.6
2.9
1.20
193
1305
(3030467) Casts [#/volume] in Urine by Automated count
161
1044
1.92
8.74
5.0
3.4
e6/l
0.4
0.6
0.86
135
807
(3019069) Monocytes/100 leukocytes in Blood
204
1432
1.88
8.64
9.8
5.5
%
9.0
8.9
0.24
194
1319
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
345
2909
2.52
8.62
6.1
5.4
mmol/l
2.4
2.5
1.92
307
2569
(3013650) Neutrophils [#/volume] in Blood by Automated count
240
1779
1.90
8.53
12.1
8.0
e9/l
4.2
4.4
0.46
220
1541
(3022096) Basophils/100 leukocytes in Blood
199
1392
1.87
8.46
9.6
5.2
%
0.6
0.6
0.01
188
1278
(3023368) Bacteria identified in Blood by Culture
168
1114
1.89
8.45
6.5
4.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
205
1453
1.86
8.31
9.6
5.5
%
25.9
25.2
0.32
194
1323
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
336
2817
2.33
8.23
5.7
4.8
mmol/l
4.3
4.4
0.62
300
2508
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
211
1513
1.85
8.20
5.4
4.5
ng/l
48.4
65.3
0.37
183
1208
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
27
5.74
8.08
2.3
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
128
787
1.93
8.02
4.6
3.2
mosm/kgh2o
502.6
552.8
2.73
115
659
(3012501) Base excess in Blood by calculation
28
85
3.47
7.95
7.0
4.6
mmol/l
3.1
2.8
0.31
22
48
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
61
3.94
7.91
7.6
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
96
3.30
7.86
1.8
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
216
1574
1.83
7.84
6.1
4.5
estimate
0.0
0.0
0.00
71
323
(3009261) Glucose [Presence] in Urine by Test strip
217
1588
1.82
7.73
6.1
4.5
estimate
0.0
0.0
0.00
67
307
(3032080) INR in Blood by Coagulation assay
217
1588
1.82
7.73
16.5
12.2
inr
1.3
1.4
0.26
86
441
(3021601) Nitrite [Presence] in Urine by Test strip
215
1570
1.82
7.70
7.7
6.1
estimate
0.0
0.0
0.00
68
317
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
223
1650
1.81
7.61
9.8
5.9
mmol/l
1.2
1.2
0.11
194
1466
(3018010) Neutrophils/100 leukocytes in Blood
199
1425
1.80
7.56
8.9
5.3
%
58.6
59.5
0.38
188
1312
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
331
2788
2.19
7.52
5.5
4.7
mmol/l
1.5
1.4
1.67
292
2455
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
657
1.94
7.44
2.4
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1313
1.79
7.35
3.8
2.8
ug/l
154.2
150.5
0.09
168
1162
(3031040) Bacteria [#/volume] in Urine by Automated count
280
2236
1.88
7.29
6.5
5.4
e6/l
237.4
4032.1
—
10
47
(3044889) 12 lead EKG panel
276
2195
1.86
7.27
5.7
4.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
148
979
1.82
7.25
5.1
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
176
1228
1.78
7.19
4.2
3.1
mmol/l
2.3
2.3
0.33
157
1044
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
16
7.04
7.18
3.5
6.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
232
1756
1.78
7.15
7.1
5.7
umol/l
12.3
11.9
0.26
219
1641
(3037467) Urinalysis macro (dipstick) panel - Urine
280
2243
1.86
7.13
7.0
4.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
150
1003
1.80
7.04
2.5
2.2
mg/l
3.5
3.2
0.50
130
836
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
321
2700
2.03
6.91
5.2
4.2
mmol/l
1.2
1.2
0.84
281
2353
(1761868) Lipid panel - Serum or Plasma
124
787
1.84
6.88
4.8
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
197
1449
1.72
6.48
5.0
4.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
92
540
1.92
6.46
4.2
2.6
%
22.9
20.8
0.73
78
464
(40767503) Oxygen content in Capillary blood by calculation
24
76
3.30
6.40
2.7
2.5
%
14.4
15.3
0.46
14
39
(3026493) Urate [Moles/volume] in Serum or Plasma
128
838
1.78
6.33
4.7
2.9
umol/l
4202.4
7639.2
0.38
108
693
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
180
1301
1.71
6.24
2.8
2.2
nmol/l
84.2
78.7
1.84
156
1112
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
171
1220
1.71
6.21
6.8
5.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
153
1067
1.71
5.99
2.9
2.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
16
6.39
5.98
2.5
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
16
6.39
5.98
2.5
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
128
851
1.75
5.94
6.8
4.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
157
1108
1.69
5.86
5.6
4.0
mg/mmol
11.9
9.5
0.23
99
689
(3004789) Transferrin [Mass/volume] in Serum or Plasma
94
573
1.84
5.83
4.2
2.5
g/l
2.2
2.2
0.56
82
521
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
230
2.24
5.79
2.1
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
100
628
1.79
5.61
4.2
2.5
umol/l
12.4
11.8
0.28
86
570
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
21
5.36
5.55
2.4
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
132
901
1.70
5.51
7.0
4.8
estimate
0.0
0.0
0.00
67
306
(3018418) pH of Serum or Plasma
155
1105
1.66
5.48
9.3
3.9
ph
7.4
7.4
0.24
49
218
(3042936) Bacteria identified in Isolate by Culture
86
520
1.84
5.45
2.2
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
50
250
2.15
5.43
2.6
3.4
ml/min/173m2
46.2
55.6
1.25
33
115
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
331
2890
1.92
5.32
6.3
5.2
mmol/l
6.1
6.2
0.29
291
2534
(3012516) Albumin [Mass/volume] in Urine
146
1032
1.66
5.30
3.9
3.1
mg/l
189.2
182.2
0.02
96
659
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
180
1346
1.62
5.20
2.4
2.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
137
2.45
4.97
3.2
2.2
u/ml
0.4
0.4
0.28
20
75
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
56
3.32
4.95
2.6
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
466
1.81
4.83
2.1
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
220
2.13
4.78
2.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
152
1108
1.61
4.77
2.9
2.1
u/l
189.9
224.7
0.34
143
1033
(3009508) Creatinine [Moles/volume] in Urine
144
1042
1.60
4.63
3.9
3.1
mmol/l
6.2
7.0
1.95
113
844
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
1034
1.60
4.61
3.1
2.4
u/l
52.9
56.8
0.92
125
948
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
99
2.63
4.56
2.1
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
49
3.36
4.52
2.6
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
89
575
1.71
4.44
4.4
2.9
mmol/l
0.8
0.8
0.77
82
529
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
849
1.60
4.17
1.9
1.9
pmol/l
442.3
17308137.4
0.80
92
676
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
74
463
1.74
4.12
2.1
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
289
2492
1.60
4.09
24.9
20.4
%
36.7
38.2
1.21
149
1477
(3025941) Bacteria identified in Stool by Culture
33
158
2.19
4.01
1.5
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
78
499
1.70
4.01
2.4
2.4
%
1.5
1.8
2.39
69
441
(3028026) IgM [Mass/volume] in Serum or Plasma
36
179
2.11
3.99
2.4
1.7
g/l
1.5
1.5
0.02
30
158
(3021901) Oxygen saturation in Capillary blood
20
76
2.72
3.96
2.5
2.4
—
—
—
0
0
(4010399)
40
208
2.03
3.94
1.7
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
274
1.90
3.93
2.2
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
114
2.37
3.87
3.2
3.0
nmol/l
0.7
0.9
1.63
20
88
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
671
1.61
3.87
1.9
1.7
mg/l
1.5
1.5
0.06
79
532
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
44
3.26
3.81
2.1
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
50
3.08
3.73
2.1
1.6
—
—
—
0
0
(3020891) Body temperature
32
157
2.13
3.67
4.9
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
381
1.74
3.67
1.7
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
34
171
2.08
3.67
1.9
1.9
ug/l
0.8
3.4
0.78
29
145
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
787
1.55
3.58
3.0
2.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
31
3.62
3.50
2.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
94
2.42
3.47
4.9
2.6
ug/min
67.1
105.4
0.35
15
51
(3004809) Band form neutrophils/100 leukocytes in Blood
17
65
2.69
3.35
4.6
3.3
%
1.2
1.8
0.40
12
54
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
72
2.57
3.26
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
33
3.40
3.21
2.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
127
957
1.48
3.19
1.7
1.6
nmol/l
23.2
20.0
1.03
108
784
(3026008) Bacteria identified in Urine by Culture
156
1225
1.45
3.17
4.4
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
190
1550
1.44
3.14
2.2
2.2
pmol/l
96.5
91.8
0.66
100
792
(3002032) Base excess in Venous blood by calculation
60
382
1.67
3.13
5.0
3.8
mmol/l
2.0
1.9
0.10
54
291
(3012544) pH of Venous blood
61
391
1.66
3.10
5.0
3.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
14
51
2.81
3.01
2.1
2.0
%
86.4
89.5
0.59
14
51
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
166
1330
1.43
2.98
5.9
5.7
ug/l
6.5
3.9
0.31
140
1148
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
292
1.73
2.95
2.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
145
2.00
2.83
2.2
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
59
2.60
2.82
3.8
3.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
153
1.97
2.79
3.2
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
339
1.65
2.72
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
58
380
1.62
2.71
4.0
2.6
e9/l
56.7
67.3
2.07
43
313
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
155
1.94
2.69
2.5
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
201
1689
1.39
2.65
3.3
3.1
u/l
61.6
55.6
0.33
187
1527
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
262
1.72
2.64
1.8
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
247
1.74
2.62
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.73
2.61
1.6
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.73
2.61
1.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.73
2.61
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.73
2.61
1.6
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
11
38
2.95
2.60
3.6
2.7
%
76.8
57.7
—
6
25
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
119
917
1.43
2.59
3.6
3.0
u/l
32.2
33.6
0.25
110
872
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
7
7.22
2.55
1.8
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
7
7.22
2.55
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
7
7.22
2.55
2.8
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
45
284
1.66
2.44
3.1
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
58
2.47
2.39
3.0
2.0
pg
33.3
32.8
0.21
14
58
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
8
6.31
2.38
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
28
3.26
2.32
1.4
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
86
2.15
2.26
1.3
1.4
ug/g
329.3
255.2
—
9
45
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
9
5.61
2.22
3.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
36
2.82
2.21
1.5
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
366
1.55
2.21
2.2
2.7
ug/l
6.0
6.3
0.04
44
317
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
99
759
1.41
2.18
3.1
3.2
mmol/l
2.5
2.5
0.42
92
656
(3035880) pH of Pleural fluid
9
30
3.05
2.16
1.4
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
627
1.43
2.15
3.8
3.1
e6/l
1.2
1.3
0.05
54
374
(3004451) EKG impression Narrative
8
25
3.24
2.10
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
89
2.07
2.09
3.1
3.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
1.4
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
15
4.04
2.04
1.8
4.2
u/l
198.5
223.3
—
6
15
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
15
4.04
2.04
1.7
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
15
4.04
2.04
1.7
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
15
4.04
2.04
1.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
38
2.67
2.02
1.5
1.6
—
—
—
0
0
(4062490)
7
21
3.37
1.97
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
68
496
1.45
1.97
1.7
1.4
g/l
3.0
2.7
0.37
47
269
(3009343) pH of Capillary blood
39
252
1.61
1.96
4.1
3.9
ph
7.4
7.4
1.03
11
30
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
236
1.63
1.96
4.0
4.0
mmol/l
2.0
1.9
0.02
29
176
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
11
4.59
1.94
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
33
2.77
1.94
1.6
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
65
2.20
1.90
3.5
2.2
%
64.1
62.0
0.11
14
65
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
24
137
1.80
1.88
2.4
2.1
ug/l
289.8
558.7
0.60
24
128
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
733
1.37
1.86
1.7
1.6
mmol/l
1.2
1.2
0.15
70
591
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
23
130
1.82
1.86
2.9
3.2
—
2.4
—
0
14
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
17
3.57
1.84
1.5
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
17
3.57
1.84
2.0
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
17
3.57
1.84
3.0
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
131
1.80
1.82
2.9
3.3
mg/l
62.0
119.2
0.56
15
101
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
131
1.80
1.82
2.9
3.3
mg/l
28.8
55.3
0.55
15
102
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
33
209
1.63
1.80
1.8
1.8
g/l
1.4
1.6
0.82
27
186
(3037756) Immunofixation for Serum or Plasma
17
88
1.97
1.77
1.8
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
30
2.70
1.73
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
30
2.70
1.73
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
46
319
1.50
1.72
7.5
8.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
99
789
1.34
1.70
8.9
6.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
55
2.22
1.69
2.3
2.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
25
2.83
1.65
1.3
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
25
2.83
1.65
2.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
136
1.73
1.62
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
2.6
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
14
3.60
1.62
1.8
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
14
3.60
1.62
1.8
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
2.6
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
32
2.53
1.60
1.5
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
598
1.36
1.56
3.8
3.3
e6/l
3.0
2.3
0.17
47
348
(3019225) pH of Specimen
49
352
1.45
1.55
6.3
4.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
33
2.45
1.54
1.6
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
15
3.36
1.53
1.8
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
86
1.90
1.52
1.1
1.2
—
2.1
—
0
9
(3030981) Hyaline casts [#/volume] in Urine by Automated count
32
211
1.56
1.51
4.3
3.3
e6/l
0.4
0.3
0.31
32
206
(44790049)
9
37
2.47
1.49
2.4
1.4
—
—
—
0
0
(44790048)
9
37
2.47
1.49
2.4
1.4
—
—
—
0
0
(44806118)
9
37
2.47
1.49
2.4
1.4
—
—
—
0
0
(44790047)
9
37
2.47
1.49
2.4
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
45
321
1.45
1.48
1.3
1.3
titre
535.4
503.3
0.05
13
72
(3003181) Sodium [Moles/volume] in Urine
15
80
1.91
1.46
1.2
1.3
mmol/l
52.9
60.6
—
9
67
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
39
2.34
1.44
3.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
31
206
1.55
1.43
5.4
4.0
%
47.7
46.1
0.13
31
200
(40761535) Cells panel - Urine sediment
43
307
1.45
1.42
5.1
3.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
46
2.20
1.41
4.2
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
112
1.73
1.38
4.3
3.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
301
1.44
1.36
7.5
3.7
ng/l
160.7
91.1
0.94
35
258
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
17
2.96
1.36
1.0
2.1
u/field
5.6
5.3
—
5
9
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
68
531
1.34
1.34
1.2
1.2
u/ml
0.8
1.8
1.26
18
122
(3011397) Hemoglobin [Presence] in Urine by Test strip
90
733
1.30
1.32
4.7
4.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
2.8
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
18
2.80
1.29
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
237
1.48
1.28
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
44
2.07
1.27
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
44
2.07
1.27
5.3
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
36
2.25
1.25
1.9
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
2.8
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
109
1.68
1.21
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
86
1.77
1.20
3.4
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
249
1.45
1.20
2.5
2.0
ug/g
118.5
157.8
0.55
27
196
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
26
2.33
1.19
1.2
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
91
756
1.27
1.14
3.6
3.2
ug/l
0.7
0.8
0.61
64
525
(3019060) Gas panel - Arterial blood
38
278
1.41
1.13
3.1
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
71
573
1.29
1.12
44.4
28.3
inr
1.3
1.3
—
10
69
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
21
136
1.57
1.11
2.4
2.3
g/l
1.0
0.9
0.05
15
112
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
245
1.42
1.10
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
106
901
1.24
1.09
2.2
1.8
nmol/l
1373.1
1201.6
0.90
81
663
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
21
2.40
1.09
1.2
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
67
1.82
1.06
1.6
1.4
g/l
30.5
30.1
0.04
12
61
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
205
1.45
1.04
2.2
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
205
1.45
1.04
5.9
4.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
53
1.91
1.02
1.9
1.4
—
—
—
0
0
(4034850)
17
107
1.62
1.01
12.8
13.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
61
1.83
0.99
1.7
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
61
1.83
0.99
1.2
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
62
1.80
0.95
1.9
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
121
1061
1.20
0.92
5.3
4.8
%
22.6
21.8
0.25
74
558
(3047181) Lactate [Moles/volume] in Blood
5
101
0.49
0.90
2.6
5.5
mmol/l
1.6
1.3
—
5
90
(3026389) Candida sp identified in Specimen by Organism specific culture
8
42
1.92
0.89
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
435
1.28
0.88
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
30
2.02
0.87
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
80
1.65
0.85
1.7
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
146
1.46
0.84
1.6
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
97
1.57
0.82
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
157
1.43
0.78
3.5
2.1
g/l
4.2
3.7
0.45
16
106
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
34
1.78
0.76
2.5
1.4
u/l
16.2
13.3
—
6
29
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
158
1.42
0.76
3.5
2.1
g/l
7.7
7.4
0.26
17
111
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
158
1.42
0.76
3.5
2.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
38
1.86
0.74
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
38
1.86
0.74
1.3
1.3
u/l
16.9
12.6
—
7
32
(4024509)
5
25
2.01
0.73
2.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
25
2.01
0.73
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
439
1.24
0.71
11.4
9.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
181
0.65
0.71
8.6
9.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
41
1.72
0.70
5.0
3.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
27
205
1.34
0.69
4.8
3.2
mmol/l
26.1
25.0
1.37
27
200
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
43
1.64
0.67
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
28
1.80
0.66
1.2
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
1.4
1.2
pmol/l
334.6
257.3
—
5
23
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
425
1.23
0.65
1.2
1.3
iu/ml
19.3
37.2
2.06
18
137
(4281824)
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
121
1.42
0.63
1.5
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
5
30
1.68
0.61
1.4
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
72
1.54
0.59
2.2
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
72
1.54
0.59
3.1
2.0
mg/l
13.5
13.6
0.00
11
63
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
53
1.52
0.58
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
35
1.73
0.58
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
81
1.50
0.57
2.5
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
55
1.46
0.56
1.1
1.1
u/l
32.0
27.8
—
8
47
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
50
428
1.19
0.51
2.5
3.8
ug/l
3.1
36.9
1.16
42
362
(3022313) Gas panel - Capillary blood
23
180
1.30
0.51
5.1
4.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
53
457
1.18
0.50
4.9
6.7
mmol/l
1.7
1.4
0.40
39
358
(40768800) Prostate Pathology biopsy report
12
84
1.44
0.50
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
145
1.33
0.49
2.3
2.7
pmol/l
4.4
4.3
0.41
14
122
(3045788) Cell count panel - Pleural fluid
7
45
1.57
0.49
1.9
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
37
314
1.20
0.43
2.2
2.4
u/l
24.7
31.2
1.24
29
254
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
23
185
1.26
0.43
1.3
1.5
%
1.8
1.7
0.11
18
153
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
56
1.44
0.43
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
149
1.29
0.42
1.2
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
32
1.57
0.42
2.8
1.5
mu/l
513.2
339.4
—
5
32
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
32
1.57
0.42
2.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.2
—
38.7
—
0
9
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
696
1.13
0.41
6.1
5.1
kg/l
1.0
1.0
—
10
102
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
79
1.40
0.41
1.1
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
34
1.48
0.40
1.6
2.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
97
1.35
0.40
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
97
1.35
0.40
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
133
1.29
0.39
7.2
5.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
1.2
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
10
72
1.40
0.37
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
78
0.64
0.36
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
99
1.32
0.36
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
45
1.34
0.34
3.7
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
88
0.68
0.33
1.8
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
74
1.36
0.32
1.4
2.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
54
1.30
0.30
1.7
1.3
mmol/l
4.2
3.9
—
7
49
(3003694) ABO and Rh group [Type] in Blood
75
691
1.11
0.30
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
174
0.80
0.30
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.6
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
55
1.28
0.30
1.3
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
64
1.26
0.27
2.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
72
1.26
0.26
2.6
2.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
75
1.20
0.25
2.6
3.2
u/ml
609.1
509.6
—
9
70
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
78
1.29
0.24
2.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
266
1.14
0.23
1.2
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
nmol/l
0.7
0.5
—
5
35
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.8
—
100.0
—
0
11
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
12
0.00
0.21
0.0
1.2
—
325.0
—
0
6
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
1.8
—
1.2
—
0
12
(44813793)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.0
—
132.2
—
0
13
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
118
1.19
0.19
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
415
1.10
0.19
4.9
4.9
%
39.5
32.7
2.64
32
260
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
59
1.19
0.18
1.6
1.3
e6/l
2.4
14.5
—
7
46
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
59
1.19
0.18
1.9
1.4
e6/l
43.3
266.8
—
7
49
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
60
1.17
0.18
2.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
68
0.73
0.17
1.2
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
734
1.06
0.15
4.5
4.0
ng/l
200.4
200.1
0.00
71
637
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
82
1.10
0.15
1.4
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
11
129
0.85
0.15
3.0
2.8
u/ml
55.9
43.0
0.13
11
124
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
93
1.19
0.14
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
93
1.19
0.14
1.6
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
100
0.80
0.13
3.0
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
405
1.07
0.12
1.1
1.3
u/ml
4.1
10.3
0.86
13
134
(3001019) Free T4 and TSH panel - Serum or Plasma
5
45
1.11
0.10
3.0
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
195
0.92
0.08
3.7
3.2
e9/l
2.9
3.9
—
10
125
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
64
1.10
0.08
2.1
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
68
1.03
0.08
1.9
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
84
1.07
0.07
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
232
0.95
0.05
3.1
3.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
140
1.07
0.04
1.9
1.2
—
59.4
—
0
8
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
161
1.06
0.03
3.2
4.0
%
0.7
0.9
1.50
17
155
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
162
1.05
0.02
3.2
3.9
%
1.2
1.6
1.53
17
156
(3037121) Protein [Mass/volume] in Urine
13
127
1.02
0.00
4.6
2.7
g/l
0.3
0.3
—
5
40
(3000492) Spirometry study
23
225
1.02
0.00
2.3
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
58
0.86
0.00
1.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
180
1.00
0.00
3.2
3.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
75.0
—
0
6
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
45.2
—
0
8
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
59
1.02
0.00
1.5
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
3696.2
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.4
—
101.8
—
0
8
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
89
1.01
0.00
1.1
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
4.0
—
118.1
—
0
9
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_NOS – Carcinoma in situ of skin, other sites/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).